Intraepithelial gammadelta+ lymphocytes: a comparative study between celiac disease, small intestinal bacterial

José Maria Remes-Troche1, Karina Adames, Antonia I Castillo-Rodal

  • 1Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Facultad de Medicina, UNAM, Mexico City, Mexico. chemaremes@hotmail.com

Insights

Increased gammadelta+ intraepithelial lymphocytes (IELs) are found in celiac disease (CD) and small intestinal bacterial overgrowth (SIBO), but not irritable bowel syndrome (IBS). This suggests gammadelta+ IELs may play a role in bacterial infections.

Area of Science:

  • Gastroenterology
  • Immunology
  • Intestinal Pathology

Background:

  • Intraepithelial lymphocytes (IELs) phenotyping is crucial in intestinal pathology.
  • Celiac disease (CD) is characterized by a marked increase in gammadelta+ IELs.
  • Knowledge regarding gammadelta+ IELs in other intestinal conditions is limited.

Purpose of the Study:

  • To quantify IELs, specifically the gammadelta+ subset, in duodenal biopsies.
  • To compare gammadelta+ IEL percentages in CD, small intestinal bacterial overgrowth (SIBO), and irritable bowel syndrome (IBS).

Main Methods:

  • Flow cytometry analysis of duodenal mucosal biopsies from 12 CD, 8 SIBO, and 10 IBS patients.
  • Isolated intraepithelial cells were labeled using monoclonal antibodies (CD103, CD3, CD7R, CD45RO, TcR gammadelta).
  • Total and subset IEL counts were expressed as percentages.

Main Results:

  • No significant difference in total IELs percentage among IBS (16.7%), SIBO (25.4%), and CD (26%) patients.
  • Significantly higher percentages of gammadelta+ IELs were observed in CD (15.7%) and SIBO (14.6%) patients compared to IBS (4.1%) patients (P<0.05).
  • No significant difference in gammadelta+ IELs was found between CD and SIBO patients (P=0.6).

Conclusions:

  • Increased gammadelta+ IEL density is characteristic but not exclusive to CD.
  • A similar increase in gammadelta+ IELs was noted in SIBO patients.
  • The gammadelta+ IEL population may be integral to combating intestinal bacterial infections.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Histology of the Small Intestine01:27

Histology of the Small Intestine

The small intestine exhibits a unique histological structure that significantly enhances its function in digestion and nutrient absorption. These structures include circular folds, villi, and various specialized cells that collectively facilitate the digestion of food.
The intestinal lining features transverse folds called circular folds, each housing fingerlike projections known as intestinal villi. These villi are covered by a layer of simple columnar epithelium, also referred to as...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...